Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex

Anatomical Record

Volumn 293, Issue 7, 2010, Pages 1214-1226

  Chu, E Y ^a   Fong, H ^b   Blethen, F A ^a   Tompkins, K A ^a,c   Foster, B L ^a   Yeh, K D ^a   Nagatomo, K J ^a   Matsa Dunn, D ^a   Sitara, D ^d   Lanske, B ^d   Rutherford, R B ^a   Somerman, M J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Fibroblast growth factor 23 (FGF23); Phex; Phosphate metabolism; Tooth development

Indexed keywords

DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; LIGAND; PHOSPHOPROTEIN; SIALOPROTEIN; SMALL INTEGRIN BINDING LIGAND; UNCLASSIFIED DRUG; FIBROBLAST GROWTH FACTOR; PHOSPHATE; SCLEROPROTEIN;

ADOLESCENT; ALVEOLAR BONE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENTIN; DENTOALVEOLAR COMPLEX; HYPERPHOSPHATEMIA; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; X LINKED HYPOPHOSPHATEMIC RICKETS; ANIMAL; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENETICS; HUMAN; JAW; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; X CHROMOSOME LINKED DISORDER;

ALVEOLAR PROCESS; ANIMALS; EXTRACELLULAR MATRIX PROTEINS; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FIBROBLAST GROWTH FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; HYPERPHOSPHATEMIA; MICE; MICE, KNOCKOUT; OSTEOCYTES; PHOSPHATES;

EID: 77954594511     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21152     Document Type: Article

References (87)

1. Abe K, Masatomi Y, Nakajima Y, Shintani S, Moriwaki Y, Sobue S, Ooshima T. 1992. The occurrence of interglobular dentin in incisors of hypophosphatemic mice fed a high-calcium and high-phosphate diet. J Dent Res 71:478-483.
2. Abe K, Ooshima T, Masatomi Y, Sobue S, Moriwaki Y. 1989. Microscopic and crystallographic examinations of the teeth of the Xlinked hypophosphatemic mouse. J Dent Res 68:1519-1524.
3. Adams CS, Mansfield K, Perlot RL, Shapiro IM. 2001. Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions. J Biol Chem 276:20316-20322. (Pubitemid 37411110)
4. Adams CS, Shapiro IM. 2003. Mechanisms by which extracellular matrix components induce osteoblast apoptosis. Connect Tissue Res 44(Suppl 1):230-239.
5. ADHR-Consortium. 2000. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348.
6. Baba O, Qin C, Brunn JC, Jones JE, Wygant JN, McIntyre BW, Butler WT. 2004. Detection of dentin sialoprotein in rat periodontium. Eur J Oral Sci 112:163-170.
7. Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B. 2005. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385-390.
8. Beertsen W, VandenBos T, Everts V. 1999. Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation [In Process Citation]. J Dent Res 78:1221-1229.
9. Bergwitz C, Juppner H. 2009. Disorders of phosphate homeostasis and tissue mineralisation. Endocr Dev 16:133-156.
10. Bianco P, Riminucci M, Bonucci E, Termine JD, Robey PG. 1993. Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. J Histochem Cytochem 41:183-191. (Pubitemid 23039097)
11. Chaussain-Miller C, Sinding C, Septier D, Wolikow M, Goldberg M, Garabedian M. 2007. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 13:482-489.
12. Chen J, Shapiro HS, Sodek J. 1992. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997.
13. D'Errico JA, MacNeil RL, Takata T, Berry J, Strayhorn C, Somerman MJ. 1997. Expression of bone associated markers by tooth root lining cells, in situ and in vitro. Bone 20:117-126.
14. Drezner MK. 2000. PHEX gene and hypophosphatemia. Kidney Int 57:9-18.
15. Dumitrescu CE, Kelly MH, Khosravi A, Hart TC, Brahim J, White KE, Farrow EG, Nathan MH, Murphey MD, Collins MT. 2009. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int 20:1273-1278.
16. Farrow EG, Davis SI, Ward LM, White KE. 2007. The role of DMP1 in autosomal recessive hypophosphatemic rickets. J Musculoskelet Neuronal Interact 7:310-312.
17. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE. 2006. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310-1315.
18. Fisher LW, Fedarko NS. 2003. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44(Suppl 1):33-40.
19. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. 2001. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280:460-465.
20. Fong H, Chu EY, Tompkins KA, Foster BL, Sitara D, Lanske B, Somerman MJ. 2009. Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse. J Periodontol 80:1348-1354.
21. Foster BL, Nociti FH, Jr., Swanson EC, Matsa-Dunn D, Berry JE, Cupp CJ, Zhang P, Somerman MJ. 2006. Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif Tissue Int 78:103-112.
22. Garringer HJ, Mortazavi SM, Esteghamat F, Malekpour M, Boztepe H, Tanakol R, Davis SI, White KE. 2007. Two novel GALNT3 mutations in familial tumoral calcinosis. Am J Med Genet A 143A:2390-2396.
23. Groeneveld MC, Everts V, Beertsen W. 1995. Alkaline phosphatase activity in the periodontal ligament and gingiva of the rat molar: its relation to cementum formation. J Dent Res 74:1374-1381.
24. Hao J, Zou B, Narayanan K, George A. 2004. Differential expression patterns of the dentin matrix proteins during mineralized tissue formation. Bone 34:921-932.
25. Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP. 1989. X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171:403-414.
26. Harris SE, Gluhak-Heinrich J, Harris MA, Yang W, Bonewald LF, Riha D, Rowe PS, Robling AG, Turner CH, Feng JQ, McKee MD, Nicollela D. 2007. DMP1 and MEPE expression are elevated in osteocytes after mechanical loading in vivo: theoretical role in controlling mineral quality in the perilacunar matrix. J Musculoskelet Neuronal Interact 7:313-315.
27. He G, Dahl T, Veis A, George A. 2003a. Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connect Tissue Res 44(Suppl 1):240-245. (Pubitemid 36395452)
28. He G, Dahl T, Veis A, George A. 2003b. Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nat Mater 2:552-558.
29. Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG. 2007. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26:75-84.
30. Hunter GK, Goldberg HA. 1994. Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 302(Part 1):175-179.
31. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. 1996. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317(Part 1):59-64.
32. Ichikawa S, Guigonis V, Imel EA, Courouble M, Heissat S, Henley JD, Sorenson AH, Petit B, Lienhardt A, Econs MJ. 2007a. Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 92:1943-1947.
33. Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. 2007b. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684-2691.
34. Ichikawa S, Lyles KW, Econs MJ. 2005. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 90:2420-2423.
35. Ichikawa S, Sorenson AH, Austin AM, Mackenzie DS, Fritz TA, Moh A, Hui SL, Econs MJ. 2009. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 150:2543-2550.
36. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA, Haussler MR. 2007. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 22(Suppl 2):V2-V10.
37. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51.
38. Kuro-o M. 2006. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 15:437-441. (Pubitemid 44297987)
39. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB. 2004. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087-3094.
40. Liu S, Quarles LD. 2007. How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637-1647.
41. Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD. 2007. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Am J Physiol Endocrinol Metab 293:E1636-E1644.
42. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. 2006. Pathogenic Role of FGF23 in Hyp Mice. Am J Physiol Endocrinol Metab 291:E38-E49.
43. Liu S, Zhou J, Tang W, Menard R, Feng JQ, Quarles LD. 2008. Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab 295:E254-E261.
44. Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM. 2006. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38:1248-1250.
45. Lu Y, Ye L, Yu S, Zhang S, Xie Y, McKee MD, Li YC, Kong J, Eick JD, Dallas SL, Feng JQ. 2007. Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. Dev Biol 303:191-201.
46. MacDougall M, Simmons D, Luan X, Nydegger J, Feng J, Gu TT. 1997. Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. Dentin phosphoprotein DNA sequence determination. J Biol Chem 272:835-842.
47. Malaval L, Wade-Gueye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux JP, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust MH, Amedee J, Vico L, Rossant J, Aubin JE. 2008. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205:1145-1153.
48. Masi L, Gozzini A, Franchi A, Campanacci D, Amedei A, Falchetti A, Franceschelli F, Marcucci G, Tanini A, Capanna R, Brandi ML. 2009. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Joint Surg Am 91:1190-1198.
49. Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro OM, Olsen BR, Lanske B. 2008. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 182:459-465.
50. Memon F, El-Abbadi M, Nakatani T, Taguchi T, Lanske B, Razzaque MS. 2008. Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? Kidney Int 74:566-570.
51. Millan JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Camacho NP, McKee MD, Crine P, Whyte MP. 2008. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777-787.
52. Murayama T, Iwatsubo R, Akiyama S, Amano A, Morisaki I. 2000. Familial hypophosphatemic vitamin D-resistant rickets: dental findings and histologic study of teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:310-316.
53. Naikmasur V, Guttal K, Bhargava P, Burde K, Sattur A, Nandimath K. 2008. Tumoral calcinosis with dental manifestations - a case report. Dent Update 35:134-136, 138.
54. Nakatani T, Ohnishi M, Razzaque MS. 2009. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Faseb J 23: 3702-3711.
55. Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS. 2008. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis Faseb J23:433-441.
56. Narayanan K, Gajjeraman S, Ramachandran A, Hao J, George A. 2006. Dentin matrix protein 1 regulates dentin sialophosphoprotein gene transcription during early odontoblast differentiation. J Biol Chem 281:19064-19071.
57. Nociti FH, Jr., Berry JE, Foster BL, Gurley KA, Kingsley DM, Takata T, Miyauchi M, Somerman MJ. 2002. Cementum: a phosphate-sensitive tissue. J Dent Res 81:817-821.
58. Papagerakis P, Berdal A, Mesbah M, Peuchmaur M, Malaval L, Nydegger J, Simmer J, Macdougall M. 2002. Investigation of osteocalcin, osteonectin, and dentin sialophosphoprotein in developing human teeth. Bone 30:377-385. (Pubitemid 34150160)
59. Pereira CM, de Andrade CR, Vargas PA, Coletta RD, de Almeida OP, Lopes MA. 2004. Dental alterations associated with X-linked hypophosphatemic rickets. J Endod 30:241-245.
60. Qin C, Baba O, Butler WT. 2004. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15:126-136.
61. Qin C, Brunn JC, Cadena E, Ridall A, Tsujigiwa H, Nagatsuka H, Nagai N, Butler WT. 2002. The expression of dentin sialophosphoprotein gene in bone. J Dent Res 81:392-394.
62. Qin C, Brunn JC, Baba O, Wygant JN, McIntyre BW, Butler WT. 2003a. Dentin sialoprotein isoforms: detection and characterization of a high molecular weight dentin sialoprotein. Eur J Oral Sci 111:235-242.
63. Qin C, Brunn JC, Cadena E, Ridall A, Butler WT. 2003b. Dentin sialoprotein in bone and dentin sialophosphoprotein gene expressed by osteoblasts. Connect Tissue Res 44(Suppl 1):179-183. (Pubitemid 36395442)
64. Qin C, D'Souza R, Feng JQ. 2007. Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis. J Dent Res 86:1134-1141.
65. Quarles LD. 2003. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1-E9.
66. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. 2003. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683-692.
67. Rios HF, Ye L, Dusevich V, Eick D, Bonewald LF, Feng JQ. 2005. DMP1 is essential for osteocyte formation and function. J Musculoskelet Neuronal Interact 5:325-327. (Pubitemid 43298848)
68. Rosen CJm. 2008. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab 7:7-10.
69. Rutherford RB, Foster BL, Bammler T, Beyer RP, Sato S, Somerman MJ. 2006. Extracellular phosphate alters cementoblast gene expression. J Dent Res 85:505-509.
70. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568.
71. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T. 2001. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505.
72. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B. 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421-432.
73. Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, Erben RG, Lanske B. 2006. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161-2170.
74. Sreenath T, Thyagarajan T, Hall B, Longenecker G, D'Souza R, Hong S, Wright JT, MacDougall M, Sauk J, Kulkarni AB. 2003. Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III. J Biol Chem 278:24874-24880.
75. Strom TM, Juppner H. 2008. PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 17:357-362.
76. Suzuki H, Amizuka N, Oda K, Li M, Yoshie H, Ohshima H, Noda M, Maeda T 2005. Histological evidence of the altered distribution of osteocytes and bone matrix synthesis in klotho-deficient mice. Arch Histol Cytol 68:371-381.
77. Suzuki H, Amizuka N, Oda K, Noda M, Ohshima H, Maeda T. 2008. Involvement of the klotho protein in dentin formation and mineralization. Anat Rec (Hoboken) 291:183-190.
78. Tartaix PH, Doulaverakis M, George A, Fisher LW, Butler WT, Qin C, Salih E, Tan M, Fujimoto Y, Spevak L, Boskey AL. 2004. In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem 279:18115-18120.
79. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E. 2004. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36: 579-581.
80. Toyosawa S, Shintani S, Fujiwara T, Ooshima T, Sato A, Ijuhin N, Komori T. 2001. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 16:2017-2026. (Pubitemid 32995392)
81. van den Bos T, Handoko G, Niehof A, Ryan LM, Coburn SP, Whyte MP, Beertsen W. 2005. Cementum and dentin in hypophosphatasia. J Dent Res 84:1021-1025.
82. Witcher SL, Jr., Drinkard DW, Shapiro RD, Schow CE, Jr. 1989. Tumoral calcinosis with unusual dental radiographic findings. Oral Surg Oral Med Oral Pathol 68:104-107.
83. Xiao NM, Zhang YM, Zheng Q, Gu J. 2004. Klotho is a serum factor related to human aging. Chin Med J (Engl) 117:742-747. (Pubitemid 38735835)
84. Ye L, MacDougall M, Zhang S, Xie Y, Zhang J, Li Z, Lu Y, Mishina Y, Feng JQ. 2004. Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem 279:19141-19148.
85. Ye L, Zhang S, Ke H, Bonewald LF, Feng J. 2008. Periodontal breakdown in the dmp1 null mouse model of hypophosphatemic rickets. J Dent Res 87:624-629.
86. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N. 2007. Mineralized tissue cells are a principal source of FGF23. Bone 40:1565-1573.
87. Zhang X, Rahemtulla FG, MacDougall MJ, Thomas HF. 2007. Vitamin D receptor deficiency affects dentin maturation in mice. Arch Oral Biol 52:1172-1179.